Yuxi Walvax

Yuxi Walvax Biotechnology is a leading Chinese vaccine manufacturer and a core subsidiary of Walvax Biotechnology. The company specializes in the research, development, and large-scale production of modern vaccines, most notably becoming the first Chinese firm to launch a domestic 13-valent pneumococcal conjugate vaccine (PCV13). Its portfolio includes high-demand products such as HPV vaccines and various conjugate vaccines for meningitis and Hib. Yuxi Walvax operates significant GMP-certified manufacturing facilities in Yunnan Province and is a key player in China's efforts to achieve self-sufficiency in high-end biological products.